Publication Venue For
Sustained blood pressure control and coronary heart disease, stroke, heart failure, and mortality: An observational analysis of ALLHAT.
Race and sex differences in asleep blood pressure: The Coronary Artery Risk Development in Young Adults (CARDIA) study.
Angiotensin II receptor blocker attenuates stress pressor response in young adult African Americans.
Drugs don’t work in patients who don’t take them.
Primary prevention of chronic kidney disease through population-based strategies for blood pressure control: The ARIC study.
Long-term efficacy and tolerability of azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide in chronic kidney disease.
The association of nocturnal hypertension and nondipping blood pressure with treatment-resistant hypertension: The Jackson Heart Study.
Measure Accurately, Act Rapidly, and Partner With Patients (MAP) improves hypertension control in medically underserved patients: Care Coordination Institute and American Medical Association Hypertension Control Project Pilot Study results.
Chronic kidney disease and incident apparent treatment-resistant hypertension among blacks: Data from the Jackson Heart Study.
The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial).
Metabolic syndrome and masked hypertension among African Americans: The Jackson Heart Study.
Evaluation of Criteria to Detect Masked Hypertension.
Dietary Total Isoflavone Intake Is Associated With Lower Systolic Blood Pressure: The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
White-Coat Effect Among Older Adults: Data From the Jackson Heart Study.
Effect of chlorthalidone, amlodipine, and lisinopril on visit-to-visit variability of blood pressure: Results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Resting energy expenditure and systolic blood pressure relationships in women across 4.5 years.
Trends in hypertension prevalence, awareness, treatment, and control among us adults 80 years and older, 1988-2010.
Author Response to Lipid-Lowering in African Americans in ALLHAT-Optimism Bias?.
Risk of Hospitalized Gastrointestinal Bleeding in Persons Randomized to Diuretic, ACE-Inhibitor, or Calcium-Channel Blocker in ALLHAT.
The Human Side of Failed Hypertension Treatment.
Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT).
Olmesartan/amlodipine/hydrochlorothiazide in obese participants with hypertension: A TRINITY subanalysis.
Changes in Vascular Hemodynamics in Older Women Following 16 Weeks of Combined Aerobic and Resistance Training.
Reply to Visit-to-Visit Blood Pressure Variation: Time to Reanalyze All The Data From the TROPHY Study.
Association Between Antihypertensive Medication Adherence and Visit-to-Visit Variability of Blood Pressure.
Randomized Study of Antihypertensive Efficacy and Safety of Combination Aliskiren/Valsartan vs Valsartan Monotherapy in Hypertensive Participants With Type 2 Diabetes Mellitus.
Blood Pressure Measurement Device, Number and Timing of Visits, and Intra-Individual Visit-to-Visit Variability of Blood Pressure.
The Role of Uric Acid in the Pathogenesis of Hypertension in the Young.
Hypertension Control Among Newly Treated Patients Before and After Publication of the Main ALLHAT Results and JNC 7 Guidelines.
Long-Term Efficacy and Safety of Triple-Combination Therapy With Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide for Hypertension.
Antiplatelet therapy for transient ischemic attack.
Mortality and morbidity during and after the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
Prevalence and Correlates of Low Medication Adherence in Apparent Treatment-Resistant Hypertension.
Refractory hypertension: Definition, prevalence, and patient characteristics.
Within-Visit Variability of Blood Pressure and All-Cause and Cardiovascular Mortality Among US Adults.
24-Hour Efficacy and Safety of Triple-Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: The TRINITY Ambulatory Blood Pressure Substudy.
Low medication adherence and the incidence of stroke symptoms among individuals with hypertension: The REGARDS study.
Efficacy of an olmesartan medoxomil-based treatment algorithm in patients stratified by age, race, or sex.
Taking less than prescribed: Medication nonadherence and provider-patient relationships in lower-income, rural minority adults with hypertension.
Prevention of Microalbuminuria in Patients With Type 2 Diabetes: What Do We Know?.
ASH Position Paper: Dietary approaches to lower blood pressure..
Efficacy and safety of long-term treatment with the combination of amlodipine besylate and olmesartan medoxomil in patients with hypertension.
ASH position paper: Treatment of hypertension in patients with diabetes - An update.
Results of an olmesartan medoxomil-based treatment regimen in hypertensive patients.
Mechanisms and treatment of resistant hypertension.
The ALLHAT study revisited: do newer data from this trial and others indicate changes in treatment guidelines?.
Comparison of increasing doses of olmesartan medoxomil, losartan potassium, and valsartan in patients with essential hypertension..
Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertension..
Renin inhibitors in the management of hypertension..
American Society of Hypertension, Inc
Efficacy and Safety of Irbesartan/HCTZ Combination Therapy As Initial Treatment for Rapid Control of Severe Hypertension.
Incidence and predictors of angioedema in elderly hypertensive patients at high risk for cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)..
Primary Aldosteronism: Diagnosis and Treatment.
Resistant or difficult-to-treat hypertension..
Conflicting and confusing data from the hypertension treatment trials: whom and what should you believe?.
Ethnicity and blood pressure..
Gender and blood pressure..
New-onset diabetes in treated hypertensive patients--is it clinically significant? Roundtable discussion..
The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study..
Interview with Suzanne Oparil, MD. Interview by Marvin Moser, MD..
Roundtable discussion: blood pressure goal attainment: meeting the challenge of the JNC 7's blood pressure goals and the role of renin-angiotensin-aldosterone system blockade..
Use of aldosterone antagonists in resistant hypertension..
Erratum: Comparative efficacy of olmesartan, losartan, valsartan and irbesartan in the control of essential hypertension (Journal of Clinical Hypertension (2001) vol. 3(5) (283-291, 318)).
Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertension.
Primary aldosteronism: A practical approach to diagnosis and treatment.
Treating hypertension in the elderly - Whom to treat, when, and with what?.
The use of transcutaneous clonidine hydrochloride in the patient with diabetes mellitus and mild hypertension..